Overview Financials News + Filings Key Docs Insiders
|
| In millions, except per share items | Dec-31-13 | Dec-31-12 | Jan-14-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 |
| | 10-K | 10-K | 10-K | 10-K | S-1/A | S-1 |
| Revenues: |
| United States | 625.0 | 564.0 | | | | |
| Specialty Amines | 531.0 | 417.0 | 61.0 | 460.0 | 357.0 | 294.0 |
| Functional Amines | 529.0 | 437.0 | 64.0 | 515.0 | 465.0 | 411.0 |
| Crop Protection | 140.0 | 118.0 | 19.0 | 148.0 | 129.0 | 120.0 |
| Other | -1,825.0 | -1,536.0 | | | | |
| Total revenues | 0.0 | 0.0 | 144.0 | 1,123.0 | 951.0 | 825.0 |
| Revenue growth [+] | | -100.0% | -84.9% | | 15.3% | |
| United States | 10.8% | | | | | |
| Specialty Amines | 27.3% | 583.6% | -82.9% | | 21.4% | |
| Functional Amines | 21.1% | 582.8% | -86.2% | | 13.1% | |
| Crop Protection | 18.6% | 521.1% | -85.3% | | 7.5% | |
| Cost of goods sold | 20.1 | 14.3 | 111.0 | 906.0 | 757.0 | 651.0 |
| Gross profit | -20.1 | -14.3 | 33.0 | 217.0 | 194.0 | 174.0 |
| Gross margin | | | 22.9% | 19.3% | 20.4% | 21.1% |
| Selling, general and administrative | | | 66.0 | 49.0 | 52.0 | 48.0 |
| Research and development | | | 1.0 | 12.0 | 13.0 | 12.0 |
| Equity in earnings | | | | -2.0 | | |
| Other operating expenses | -23.1 | -14.3 | 1.0 | 16.0 | 2.0 | 13.0 |
| EBITDA [+] | | | -28.0 | 210.0 | | 183.0 |
| EBITDA growth | | -100.0% | -122.0% | | -30.6% | |
| EBITDA margin | | | -19.4% | 18.7% | 13.4% | 22.2% |
| Depreciation and amortization | | | 7.0 | 72.0 | | 82.0 |
| EBIT [+] | 3.0 | 0.0 | -35.0 | 138.0 | 127.0 | 101.0 |
| EBIT growth | | -100.0% | -127.6% | | 25.7% | |
| EBIT margin | | | -24.3% | 12.3% | 13.4% | 12.2% |
| Non-recurring items | 3.0 | | | | | |
| Interest expense | | | 8.0 | 75.0 | 74.0 | 80.0 |
| Interest expense | 1.5 | 0.5 | 8.0 | 75.0 | 74.0 | 80.0 |
| Other income (expense), net [+] | 1.5 | 0.5 | -2.0 | 1.0 | 2.0 | -21.0 |
| Other | | | | | 2.0 | |
| Pre-tax income | 0.0 | 0.0 | -45.0 | 64.0 | 55.0 | 0.0 |
| Income taxes | 0.0 | 0.0 | 9.0 | 32.0 | 33.0 | 16.0 |
| Tax rate | | | | 50.0% | 60.0% | |
| Net income | 0.0 | 0.0 | -54.0 | 30.0 | 22.0 | 0.0 |
| Net margin | | | -37.5% | 2.7% | 2.3% | 0.0% |
| |
| Basic EPS [+] | | $0.00 | ($0.05) | $0.03 | $0.02 | $0.00 |
| Growth | | -100.0% | -345.5% | | | |
| Diluted EPS [+] | | $0.00 | ($0.05) | $0.03 | $0.02 | $0.00 |
| Growth | | -100.0% | -345.5% | | | |
| |
| Shares outstanding (basic) [+] | | 49.0 | 1,000.0 | 1,000.0 | 1,000.0 | 1,000,000,000.0 |
| Growth | | -95.1% | 0.0% | | -100.0% | |
| Shares outstanding (diluted) [+] | | 49.0 | 1,000.0 | 1,000.0 | 1,000.0 | 1,000,000,000.0 |
| Growth | | -95.1% | 0.0% | | -100.0% | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|